InspireMD, Inc. (NSPR)
1.00
-0.05
(-4.76%)
USD |
NASDAQ |
May 19, 16:00
1.00
0.00 (0.00%)
After-Hours: 20:00
InspireMD Research and Development Expense (Quarterly) : 4.763M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AngioDynamics, Inc. | 7.084M |
| Lifeward Ltd. | 5.845M |
| Abbott Laboratories | 767.00M |
| Accuray, Inc. | 8.178M |
| Alphatec Holdings, Inc. | 17.56M |